Two-year follow-up of acromegalic patients treated with slow release lanreotide (30 mg).
Baldelli R, Colao A, Razzore P, Jaffrain-Rea ML, Marzullo P, Ciccarelli E, Ferretti E, Ferone D, Gaia D, Camanni F, Lombardi G, Tamburrano G.
Baldelli R, et al. Among authors: tamburrano g.
J Clin Endocrinol Metab. 2000 Nov;85(11):4099-103. doi: 10.1210/jcem.85.11.6948.
J Clin Endocrinol Metab. 2000.
PMID: 11095439
Clinical Trial.